日本産科婦人科学会雑誌
文字サイズ
第42巻 第8号 目次
表紙
目次
定款改訂について
第43回総会ならびに学術講演会予告 (第3回)
第44回学術講演会特別講演演者の推薦
第44回学術講演会シンポジウム課題の決定ならびに担当希望者公募
第45回学術講演会シンポジウム課題公募
臨床・研究遂行上倫理的に注意すべき事項に関する見解の一覧
定款
定款施行細則
役員および評議員選任規程
認定医制度規約
認定医制度規約施行細則
投稿規定
第23回日本医学会総会案内
第13回国際産科婦人科連合(FIGO)世界大会案内(第2回)
第13回アジア・オセアニア産科婦人科連合(AOFOG)大会案内 (第2回)
中高年女性とオステオポローシス
生殖内分泌および周産期医学領域におけるインスリンの意義
子宮頚部の初期癌ならびにその関連病変
子宮頚癌ウイルス発癌の可能性に関する研究 (<シンポジウム>子宮頚部の初期癌ならびにその関連病変)
子宮頚部扁平上皮・頚管腺上皮の分化調節機序の解析に基づく頚癌初期発生過程の研究 (<シンポジウム>子宮頚部の初期癌ならびにその関連病変)
子宮頚部初期癌と関連病変におけるHPVの発癌性に関する分子生物学的研究 : とくに16型, 18型E6/E7 mRNA局在について (<シンポジウム>子宮頚部の初期癌ならびにその関連病変)
子宮頚癌の発生におけるウイルス学的病因論 : 感染から発癌まで (<シンポジウム>子宮頚部の初期癌ならびにその関連病変)
討論
精神神経疾患 (<教育講演>合併症妊娠における胎児・新生児管理)
甲状腺疾患 (<教育講演>合併症妊娠における胎児・新生児管理)
自己免疫疾患 (<教育講演>合併症妊娠における胎児・新生児管理)
乳汁分泌の内分泌性調節
卵巣癌の治療とフォローアップ
生殖医学における動物実験モデル
Program of the 42nd Annual Scientific Meeting
1 A study of preincubated gamete intra-Fallopian transfer using a small number of sperm.
2 Results of GIFT in the treatment of male infertility : analysis by zona-free hamster egg sperm penetration test (ZSPT).
3 The examinations of Hamster test and IVF-ET using the micro culture system.
4 Application of microfertilization to patients with severe oligo-asthenozoospermia.
5 A study of microfertilization in mouse and human.
6 Short-term used protocol of GnRH agonist in combination with human menopausal gonadotropins for IVF-ET.
7 Hormonal changes induced by Gn-RH agonist during ovarian hyperstimulation for in vitro fertilization.
8 Comparison of the outcome of IVF-ET and the estradiol response.
9 Results of IVF-ET on outpatient bases during one year.
10 Treatment of resistant infertile patients by new technology.
11 Direct Intraperitoneal Insemination (IPI) for the treatment of refractory infertility related with impaired tubal sperm transport.
12 Stimulation of early embryonic development in the mouse by coculture with rabbit oviduct epitherial cells.
13 Effects of uterine epithelial cells and uterine fluids on mouse pre-implantation embryos.
14 The effects of SOD and low oxygen culture on mouse embryos.
15 Effect of EGF on the preimplantation development of mouse embryos fertilized in vitro.
16 Influence of Epidermal Growth Factor (EGF) on the Development of Mouse Embryos.
17 Translational regulation of ribosomal protein mRNAs in the early embryogenesis of Drosophila melanogaster.
18 Structure of the glucose utilization system in developing oocytes and preimplantation embryos from mice.
19 Simultaneous intracellular pH and Ca measurement during fertilization of mouse with pH and Ca sensitive fluorescent.
20 Chromosome analysis of unfertilized human oocytes in an IVF program.
21 Evaluation of different biopsy methods of preimplantation mouse embryos.
22 THE PREDICTIVE VALUE OF THE SPERM SURVIVAL TEST IN IVF-ET.
23 Alkaline/hyperosmosis on the motility of human spermatozoa.
24 Effect of Ca^<2+>-free medium on fertilizing ability of human sperm.
25 Heat resistance of mammalian sperm nuclei.
26 Fertilizing capacity of fresh and frozen human spermatozoa.
27 Sperm penetration test using hamster frozen ova : correlation between sperm motion parameters by Computer assisted semen analyser.
28 Correlation between the sperm penetration assay using zona free hamster ova and human in vitro fertilization.
29 Strictly normal sperm morphology is a good predictor of human IVF outcome.
30 Prediction of fertilizing capacity in vitro in the patients with male infertility by detailed analysis of sperm morphology.
31 Zona induced acrosome reaction of human spermatozoa.
32 Effect of platelet activating factor on capacitation and the acrosomereaction in mouse sperm.
33 Changes in protein phosphorylation during sperm acrosome reaction.
34 Clinical significance of sperm antibody detected by immunobead test.
35 Association of HLA antigens and sperm immobilizing antibodies in subfertile women.
36 Effect of antisperm antibodies in males on in vitro fertilization.
37 Sperm-immobilizing and fertilization-blocking monoclonal antibody recognizing a peptide epitope of sperm coating antigen.
38 Monoclonal Antibodies Which Immobilize or Agglutinate Fresh Ejaculated Sperm, Established by Human Trophoblast Immunization.
39 Analysis of antigens corresponding to human and mouse monoclonal antibodies with human sperm immobilizing activity.
40 Isolation of a peptide fragment including an antigen epitope cross-reactive to porcine and human zonae pellucidae from porcine ZP4.
41 Effect of several factors on human oviduct epithelial cell culture.
42 The influence of danazol (D) tamoxifen (T) and medroxyprogesterone (M) on human oviductal epithelium.
43 Effect of human aromatase inhibiter to the stimulatory effect of steroids and gonadotropin in rat's follicles.
44 Inhibition of the FSH binding to its receptor by 52 KD substance in the porcine follicular fluid.
45 Analysis of the Amino Acids and Organic Acids in Human Follicular Fluid.
46 A study on estimation of the condition in the mid-luteal endometrium with preovulate serum estradiol level.
47 Study with the luteal function in the view of the follicular development.
48 Studies on the mechanism of the ovarian enlargement during gonadotropin therapy.
49 Changes of coagulability and fibrinolytic activity in the patient of ovarian hyperstimulation syndrome (OHHS) : focused in molecular markers.
50 Investigation of efficacy of combined gonadotropin - releasing hormon analog and exogenous gonadotropins for ovulation induction in polycystic ovary syndrome.
51 Gonadotoxicity of anti-neoplastic drugs.
52 Comparison analysis of various detection methods for the presence of HPV.
53 Prevalence of Human Papillomavirus (HPV) among patients with uterine precancerous and cancerous state and results of their short term follow-up survey.
54 Detection of human papillomaviruses in cervical premalignant lesions by low stringent hybridization.
55 Presence of human papillomavirus genome in gynecologic tumor cell lines.
56 Specific and highly sensitive detection of human papillomavirus in cervical lesions by means of polymerase chain reaction (PCR).
57 Amplified DNA detection of HPV types 16 and 18 E7 gene in cervical scrapes by polymerase Chain Reaction.
58 Detection of human papilloma virus (HPV) type 16 and 52b in cervical cancer tissues by Southern blot hybridization and polymerase chain reaction (PCR).
59 Heterogeneous human papillomavirus (HPV) are present in female genital tract.
60 Chromosomal change associated with in vitro cell transformation and in vivo tumor formation by HPV16E7 and several transforming genes.
61 Transformation of primary cultured rat embryonal fibroblast by HPV16E7 region.
62 Tumorigenic transformation of primary cells by human papillomavirus types 16 and 18.
63 A novel monoclonal antibody against squamous cell carcinoma.
64 Expression of the retinoblastoma (RB) antioncogene in the cervical cancer cells.
65 Suppression of tumorigenicity by introduction of normal human chromosome 11 into HeLa sublines.
66 Estrogen- and Progesterone-Receptor Expression in Normal and Neoplastic Squamous Epithelium of the Uterine Cervix.
67 Topographic Localization of ATL-derived factor (ADF) and Human Papillomavirus DNA in Neoplastic Cervical Epithelium.
68 Analysis of HPV DNA localization in adenocarcinoma and related lesions of the uterine cervix by in situ hybridization.
69 Expression of m-RNA by in situ hybridization with photobiotinylated DNA probes of HPV16 and Hras oncogene.
70 Immunohistochemical study of EGF receptor and c-myc oncogene product in CIN and the relationship between their expression and HPV infection.
71 Characteristics of localization of human papillomavirus DNA and expression of epidermal growth factor receptor in cervical cancer.
72 Changes in HPV DNA and their relation with EGF-R and local immunity in the uterine cervix.
73 Analysis of proliferative activity in mouse experimental cervical carcinomas using BrdU incorporation and expression of c-myc protein.
74 Coexpression of EGFR and c-erb-B-2 mRNA in cultured cell lines derived from gynecological squamous cell carcinoma. : Comparative study of RT-PCR method and Northern blotting method.
75 Squamous cell carcinoma of the ceterine cervix and growth factors.
76 Effect of EGF on the proliferation and production of tumor makers of squamous cell carcinoma of uterine cervix.
77 Correlation between immunohistochemical findings and survival following radiotherapy in adenocarcinoma of the uterine cervix.
78 Mucosubstance histochemistry of uterine cervical adenocarcinoma and its related tumor.
79 Analysis and clinical application of monoclonal antibody against a human uterine cervical cancer cell line OMC-4.
80 A study on the induction of differentiation in a small cell carcinoma cell-line of the uterine cervix.
81 Establishment of argyrophil small cell carcinoma of the uterine cervix.
82 Study of the host protect system in the cervical cancer.
83 Immunohistochemical observation of Langerhans cells and tumorinfiltrating lymphocytes in invasive squamous cell carcinoma of the cervix.
84 An immunohistochemical analysis on the regional immuno-response of cervical cancer.
85 Morphological and immunological study of regional lymph node in uterine cervical cancer.
86 Effects of TNF on the production of SCC antigen.
87 Analysis of antiproliferative activity of recombinant human tumor necrosis factor by Δ^<12>-prostaglandin J_2 on gynecologic tumor cell lines.
88 Effects of antineoplastic prostaglandins on immune system.
89 The significance of "Vessel permeation" in early invasive cervical cancer.
90 Prognostic factors and adjunctive treatments in patients after radical hysterectomy of stage IB cervical carcinoma.
91 The study on the significance of peritoneal washing cytology for cervical carcinoma.
92 Therapeutic Limitation of Simple Hysterectomy for Early Adenocarcinoma of the Uterine Cervix.
93 Ultrasound guided percutaneous fine needle aspiration biopsy in the management of paraaortic lymph node metastasis in gynecologic malignancies.
94 Combination treatment of chemotherapy, radiotherapy and surgical treatment in advanced cervical cancer.
95 Preoperative combination chemotherapy consisting of Cisplatin, Vinblastin and Pepleomycin (PVP) for the carcinoma of the cervix resistant to the radiotherapy.
96 The measurment of total Pt and free Pt concentrations in plasma, and Pt concentrations in carcinoma tissue of CDDP intra-arterial infusion chemotherapy in uterine cervical cancer.
97 Hyperthermochemotherapy with intra-arterial infusion by vascular access device in uterine cervical cancer.
98 Evaluation of postoperative adjuvant radiation in the patients with carcinoma of the uterine cervix.
99 A Role of Combined Radiation Therapy and Hysterectomy in the Treatment of Carcinoma of the Uterine Cervix.
100 Transrectal ultrasonically guided fine needle aspiration biopsy in the management of cervical carcinoma following primary radiation therapy.
101 Histometrical study of the radiosensitivity of uterine cervical carcinoma.
102 Radiation sensitivity and immunohistochemical localigation of superoxide dismutase (SOD) in gynecologic cancer.
103 Radiosensitivity of human uterine cervical adenocarcinoma cells grown as multicellular spheroids.
104 Changes in fatty acid composition in breast milk and maternal plasma.
105 Effect of prenatal stress on behaviors of the rat.
106 The influence of psychological stress on the suckling-induced oxytocin release.
107 Effect of maternal exercise on the fetal heart rate.
108 Serial blood volume determination during normal pregnancy.
109 Gestational changes in mechanical properties of skinned muscle tissues of human myometrium.
110 Direct measurement of intracellular free calcium in human puerperal myometrial cells stimulated by oxytocin : effects of extracellular calcium and calcium channel blockers.
111 Superoxide anion increases intracellular free calcium in human myometrial cells.
112 Modification by magnesium on the excitatory effect of oxytocin in electrical and mechanical activities of pregnant human myometrium.
113 Uterine, cervical and bladder contractility in the rats during pregnancy and after delivery : Responses to hypogastric and pelvic nerve stimulation in vivo.
114 The contractile responses of the rabbit myometrium to the field stimulation : Possible concernment with adenosine 5'-triphosphate (ATP).
115 Mechanical responses to prostaglandins (PGs) and effect of PGs on c-AMP content in the rabbit uterine cervical smooth muscle.
116 Partial purification and characterization of phosphoinositide-specific phospholipase C (PLG) from human myometrium.
117 Effect of steroids on PNMT (phenylethanolamine-N-methyltransferase) activity in human pregnant myometrium.
118 THE SELECTIVITY OF TRANSFER OF VARIOUS SUBSTANCES PARTICIPATING IN HUMAN PARTURITION THROUGH THE FETAL MEMBRANES.
119 The effect of fetal catecholamines on human decidual prostaglandin biosynthesis.
120 Investigation of pregnancy related substances in the urine of pregnant women using HPLC.
121 Effects of relaxin to ripening of the rat uterine cervix.
122 Liver kininogen mRNA in pregnant spontaneously hypertensive rat and the effect of sodium intake.
123 Changes of serotonin (5HT) metabolites and catecholamin (CA) metabolites for pregnant women : Changes at delivery.
124 The effect of endogenous human atrial natriuretic peptide on the vascular system in pregnancy induced hypertension and pregnancy aggravated hypertension.
125 The mechanism of decreasing circulating leukocyte in toxemia of pregnancy in comparison with normal pregnancy.
126 A study on classifying gestosis as seen from the placenta.
127 On the Difference in the Mode of New Formation of Villi between Villi in Early Stages of Pregnancy and Villi of Placenta in Gestational Toxicosis.
128 Growth suppression factor against endothelial cells in preeclampsia.
129 The function of fibrin-clot reduction on syncytial cell of toxemic pregnancy.
130 Placental circulation maintaining mechanism-platelet aggregation inhibiting activity of placental brush border membrane (BBMV).
131 Studies on LTV and FHR Changes before and after Start of Labor Pains and Placental Function by Neonatal Birth Weight/Placental Weight Ratio in Reactive Cases.
132 Effects of a Thromboxane Synthetase Inhibitor (OKY-046) on Vascular Reactivity to Angiotensin II in Pregnant Rabbits with Stenosis of the Abdominal Aorta.
133 Urinary 11-dehydro TXB2 during toxemic pregnancies.
134 Effects of PGI2, TXA2 and Serotonin on uteroplacental blood flow in hypertensive pregnant rats.
135 The role of superoxide dismutase (SOD) and prostanoids in gestosis.
136 Surfactant lecithin increases Prostaglandin E production in human amnion not as a substrate.
137 Vascular sensitivity to Angiotensin II (A-II) in the increased intrauterine resting tonus (IIURT) of pregnant rabbits. : Significance of EDRF.
138 Pathophysiological significance of intracellular ionized calcium and sodium in pregnancy induced hypertension.
139 PREDICTION OF PREGNANCY INDUCED HYPERTENSION.
140 Significance of microalbuminuria in the prediction of pregnancy induced hypertension.
141 Postural change of blood flow at lower extremity and effectiveness on recurrence of toxemia, using "Mat".
142 The relationship between anti-phospholipid antibodies' level and pregnant outcomes.
143 Prostacyclin synthesis in recurrent abortion with antiphospholipid antibody.
144 Lupus anticoagulant in the pregnancies with SLE.
145 Autoimmune mechanisms in habitual abortion.
146 Clinical significance of antiphospholipid antibodies in patients with habitual abortion and systemic lupus erythematosus associated with fetal loss.
147 Reactivity of the sera with anti-phospholipid antibodies of the patients with recurrent spontaneous abortion and endometriosis to placental villi.
148 Study of localization and activity of 15hydroxyprostaglandin dehydrogenase (PGDH) in human placenta and fetal membrane.
149 Analysis of PGDH inhibitor in human placenta by gas chromatography and mass spectrometry.
150 ATP-dependent protease in human placenta.
151 Indentification of two subtype forms of protein kinase C in human placenta.
152 Changes of adenosine concentration in the human maternal plasma and 5'nucleotidase activity in the chorionic placenta during parturition.
153 Inhibition of phospholipase A_2 by Calphobindins.
154 Carbonic anhydrase (CA) activity in the perfused guinea pig placenta.
155 Effect of pyridoxal phosphate loading on Tryptophan and Kynurenine in maternal venous plasma, umbilical arterial and venous plasma.
156 Transport of Urea in the Fetal Period : Analysis of urea transport system in human placenta.
157 The influence of experimental pulmonary hypoplasia due to oligohydramnios on lung growth and pulmonary surfactant production in fetal rabbit.
158 Analysis of ACh-induced vasoconstrictor responses of isolated and perfusion human umbilical arteries.
159 Hypoxia-induced contractions of human umbilical arteries depend on intact endothelium.
160 Influence of ω3-Polyunsaturated Fatty Acid Deficiency on Learning Ability of Rats.
161 Evidence for the effect of nucleosids-mixture on the anoxic damage of brain mitochondrial functions in neonatal rat.
162 The study on phisiological aspects of the individual fetus in multiple pregnancies.
163 The prognosis of the survived infant coexisting with a dead cotwin in monochorionic twin pregnancies.
164 Serial measurement of resistance index of celiac artery and superior mesenteric artery in the newborns of neonatal asphyxia, intial vomiting and necrotizing enterocolitis.
165 Change in the T/QRS in electrocardiogram during fetal heart rate deceleration in lamb fetuses.
166 Effect of oxygen administration in pregnant goats during acidosis.
167 The change of arginine vasopressin and atrial natriuretic peptide during fetal hypoxia.
168 Effect of β-blocker administration on fetal cardiovascular responses to acute hypoxemia in chronically instrumented goat fetuses.
169 Changes in fetal breathing movements during persisting hypoxemia in chronically instrumented pregnant sheep.
170 Effect of 6-hour hypoxemia on breathing activity and fetal heart rate acceleration in goat fetuses.
171 An evaluation of the dissociation of behavioral state and electro encephalogram in fetus sheep.
172 Study on the functional development of the fetal central nervous system by using the extra-uterine incubation of the goat fetus.
173 THE EFFECTS OF ARGININE VASOPRESSIN ON FETAL BREATHING MOVEMENTS.
174 The effects of adenosine on fetal breathing, eye movements, and sleep state.
175 The functional maturation of central nervous system observed by the biological rhythm.
176 Effects of maternal anti-epileptic drug on fetal behavior.
177 Clinical features of pregnancy with a IUGR fetus delivered between 24-31 weeks' gestation.
178 Arginine vasopressin (AVP) level in umbillical artery of IUGR with hypoxemia and acidemia.
179 Maternal hyperoxygenation therapy and cord blood gasses measured at cordocentesis in type II-IUGR fetuses.
180 A low dose aspirin therapy for preventing recurrent IUGR.
181 Hematologic evaluation of fetus of mother with severe preeclampsia.
182 Evaluation of fetal well-being measuring fetal adrenal glands and maternal steroids hormones.
183 A study on IGF-I in maternal plasma and amniotic fluid during pregnancy.
184 The biological significance of insulin-like growth factor I and its binding protein on fetal growth.
185 STUDIES ON THE ONTOGENESIS AND THE REGULATORY MECHANISMS OF IGF-I CIRCULATING FORMS IN FETAL LIFE.
186 Studies of Nerve Growth Factor (NGF) mRNA in human placenta using oligo DNA probe.
187 Serum 19-hydroxyandrostenedione levels in fetus and neonate.
188 Changes in intrapartum secretion of fetal ACTH, F, FSH, GH and PRL.
189 Transmigration of Prenatally Administered Vitamin K_2 into Mother's Milk.
190 Placental transfer of vitamin K1 near and at term.
191 Perinatal brain damage with abnormal fetal heart rate patterns.
192 Intracranial hemorrhage in full-term infants detected by cranial ultrasound.
193 Study of cerebral hemodynamics in fetus and neonates to predict perinatal intracranial hemorrhage.
194 Viability & Morbidity Rate of Extremely Small Infants and Their Impact on the Decison Making of the Timing to Terminate Pregnancy.
195 Effect of at birth surfactant administration.
196 Doppler studies of fetal renal artery flow waveform and its relation to fetal weight, amniotic volume and fetal urine production.
197 The relationship of fetal blood gases and pH to Dopper investigations of fetal circulation.
198 Evaluation of perinatal morbidity by velocimetry using pulsed Doppler method.
199 Assessment of fetal distress utilizing the pulse Doppler method.
200 Analysis of fetal blood flow waveform in high-risk pregnancy with pulsed Doppler system : Evaluation of pulsatility index and resistance index in fetuses associated with pregnancy induced hypertension and/or intrauterine growth retardation.
201 The study of cerebrohemodynamics in pregnant women with toxemia using pulsed Doppler velocimetry.
202 Uterine artery pulsatility index in pregnant ewes and pregnancy-induced hypertensive women.
203 Use of Doppler fetal blood flow patterns in the prediction of fetal distress.
204 Blood flow characteristics in the middle cerebral artery in normal and growth-retarded human fetuses.
205 The change of umbilical blood flow velocity waveforms during fetal hypoxia in Shiba goat experiments.
206 Studies on the cell kinetics of human mndometrium.
207 The levels of prostaglandins in endometrial tissues with and without endometriosis.
208 Biochemical study on the biosynthesis of platelet activating factor in human endometrium.
209 GSH-Peroxidase activity in endometrial cancer and its relation to the effect of chemotherapy.
210 Platelet activating factor on decidual reaction of the endometrium in mice.
211 Effects of Interleukin 1β on prostaglandin formation in endometrial stromal cells.
212 Synthesis of 12 hydroxy eicosatetraenoic acid in human endometium and decidua.
213 In vitro implantation model for pursuit of infertility.
214 The Localization of Fibronectin on the Rat Endometrium during Estrus and Pregnancy.
215 The different expression and biosynthesis of glycolipids in human endometrium during the menstrual cycle.
216 Changes in glycolipids composition in the development of mouse mammary glands.
217 Expression of macrophage colony-stimulating factor and its receptor in human placenta and pregnant uterus.
218 Expression of the corticotropin-releasing hormone (CRH) gene and gene products in human developing placenta and amniotic membrane.
219 Abnormal Antibodies in the Blood with Pelvic Endometriosis.
220 Immunological studies in endometriosis patients.
221 Concentrations of interleukin 1 (IL-1), tumor necrosis factor (TNF), and interferon (IFN-γ) in peritoneal fluid, and production of IL-1 and TNF by peritoneal macrophages from patients with or without endometriosis.
222 Effect of danazol to the estrogen binding sites of peripheral blood monocytes.
223 New experimental model for endometriosis.
224 Local Pharmacotherapy for Endometriosis : Basic study using an experimental model and its clinical application.
225 Evaluation of hysteroscopy or autoantibody in the diagnosis of adenomyosis.
226 The relationship between the pregnancy rate and the site of pelvic involvement with endometriosis.
227 Effects of crystallized human- and ovine- prolactin and human hyperprolactinemic serum induced by metoclopramide (MCP) on steroidogenesis in cultured human- and porcine-granulosa cells.
228 Effects of estrogen and FSH on the expression of aromatase in rat granulosa cells.
229 The control mechanism of progesterone production in the ovulatory process of rats.
230 Phosphorylation of Ca^<2+> /calmodulin-dependent protein kinase II in the crude extract of cultured rat granulosa cells.
231 Bovine theca and granulosa interaction promote growth and alterations in morphology and function.
232 Effect of peripheral blood lymphocytes on progesterone production by cultured human granulosa luteal cells.
233 Inhibitory Effects of Interferons on Progesterone Secretion by Human Granulosa Luteal Cells in Culture.
234 Regulation of oxytocin gene expression in early bovine luteal cells.
235 A study about GTP-binding protein in rat cultured luteal cells.
236 Effects of corticosterone on luteal function in mid-pregnant rats.
237 Release of progesterone (P_4) and cAMP from rat luteal cells in pregnancy modified by Insulin, IGF-1, MSA.
238 Effects of lipoxygenase pathway on progesterone production by human corpora lutea.
239 Affinity of purified estrogen receptor for immobilized single-stranded DNA and double-stranded DNA.
240 Estrogen receptor mRNA in rat ovaries and testes.
241 Immunohistochemical analysis of estrogen receptors in ovarian endometriosis.
242 Detection of ERmRNA in the human uterine leiomyoma.
243 Changes of endometrium estrogen receptor in patients with "Endo-metrial Insufficiency".
244 19-hydroxyandrostenedione in human ovarian vein.
245 Significance of insulin action during the mensturial cycle : Changes of testosteron and insulin between follicular and luteral phases.
246 Hyperinsulinemia and hyperandorogenism in obese women.
247 Effects of transvaginal follicular puncture (TFP) following hMG administration in patients with polycystic ovary syndrom (PCO).
248 Regulation of LH-βmessenger ribonucleic acid during gonadotropin releasing hormone agonist (GnRHa) treatment in the immature female rat.
249 Effects of a single administration of long acting LH-RH analog (LH-RHa) on hypothalamic-pituitary-ovarian (HPO) axis in mature female rats.
250 Direct ovarian effects of gonadotropin releasing hormone agonists.
251 Effects of gonadotropin-releasing hormone agonists on meiotic maturation of follicle-enclosed oocytes in rabbits.
252 Examination of steroidogenesis modulating by GnRH by the Ca^<2+> and phospholipid-dependent PK-C pathway in rat ovarian granulosa cells.
253 Effects of nicotine on ovarian function in the rat with Gn-RH agonist administration.
254 Tumor markers and main symptoms in a case of ruptured benign ovarian teratoma.
255 Normal-sized ovarian carcinoma : Study of five cases.
256 An operated case of gestational ovarian choriocarcinoma fomed a huge abdominal tumor.
257 Successful ovulation induction, conception and delivery in a case of pituitary dwarfism complicated with diabetes insipidus and primary amenorrhea.
258 Evaluation of tumor markers in ovarian dermoid cyst.
259 Clinical evaluation of newly developed serum tumor markers, SLX, CA54/61, and CA602 in ovarian cancers.
260 Clinical usefulness to assay serum levels of CA54/61 and CA602 in ovarian cancer.
261 The possible clinical application of P-450 in human fetal livers. : compared with present tumor markers.
262 Clinical usefulness of various sugar-chains tumor markers.
263 The levels of human placental form of glutathione S-transferase (GST-π) in sera of gynecological patients.
264 Development of highly sensitive enzyme-immunoassay to measure urinary hCGβ-core fragment in cancer patients.
265 Clinical application of Magnetic Resonance Imaging on the uterine anatomy and endometrial carcinoma.
266 Magnetic Resonance Imaging of Endometrial Cancer : The Value of Gd-DTPA Enhanced MRI.
267 The significance of MRI in the diagnosis of uterine corpus diseases.
268 MR imagings of uterine myomas.
269 Color and pulsed Doppler ultrasonic assessment with tumor vascularity of gynecologic neoplasm.
270 Transrectal ultrasonic assessment of parametrial infiltration of uterine cervical cancer.
271 Changes in thickness and texture of the endometrium in natural and clomiphene cycle.
272 Ultrasonographic evaluation of the tocolytic therapy.
273 A new hysterofiberscope with a simple perfusion device.
274 Levels of thrombin-antithrombin III complex and FDP in patients with ovarian cancer.
275 Immunohistochemical detection of uterine corpus cancer peroxidase using monoclonal antibody and its application to diagnosis of the cancer.
276 Comparison of hCG level in Douglas's pouch fluid with serum hCG level and serum progesterone level in ectopic pregnacy.
277 Study for the necessity of seminal culture test, seminal viscosity test and plasma prolactine measurement in unexplained male infertility.
278 Application of body fat rate determined by infrared spectrometry to evaluation of obesity.
279 Chromosomal aberraions observed by SEM.
280 Prenatal diagnosis of Duchenne muscular dystrophy (DMD) using restriction fragment length polymorphisms analysis.
281 Application of polymerase chain reaction to prenatal diagnosis : Fetal sexing using a Y specific DNA sequence.
282 The measurement of maternal serum AFP in the mid trimester of pregnancy for the screening of fetal chromosomal anomalies.
283 Mass Screening for Ovarian Cancer by Transvaginal Ultrasonography.
284 Mass screening of the ovarian tumors of young women with ultrasonography.
285 Role of initial surgery in ovarian cancer.
286 Effect of radical surgery and high-dose cyclic CAP therapy on the prognosis of ovarian cancer.
287 The prognotic value of second look laparotomy in ovarian cancer.
288 Combination therapy with hyperthermia for ovarian cancer.
289 High-dose Chemotherapy with Autologous Bone Marrow Transplantation (ABMT) in Ovarian Cancer.
290 Pharmacokinetics and toxicity of intraperitoneal cisplatin and etoposide.
291 Pharmacokinetic analysis of cisplatin, carboplatin and 254-S(intra-venous versus intraperitoneal infusion) and comparison of ultrafiltrable Pt value by chemical assay and bioassay.
292 Human ovarian cancer cell lines resistant to doxorubicin or cisplatin are sensitive to 7-prostaglandin A1 and 12-Prostglandin J2.
293 Expression of a human multidrug resistance gene in human ovarian carcinoma cell line.
294 Immunohistochemical evaluation of mdr1 gene expression in ovarian carcinomas.
295 Analysis of K-ras,HER-2/neu and c-myc oncogene amplification and overexpression in human ovarian cancer.
296 C-myc oncogene expression as prognostic factor of ovarian cancer.
297 Study on DNA ploidy of primary epithelial ovarian cancer.
298 Flow cytometric analysis of cellular DNA content in recurrent ovarian carcinomas.
299 Presumption of malignant ovarian carcinoma prognosis by analyzing nuclear DNA.
300 Study on serum levels of tumor markers and histological localization in ovarian tumor.
301 Studies of tissue localization of Sialosyl-Tn antigen in ovarian tumors.
302 Role of Manganese Superoxide Dismutase in Ovarian Carcinoma.
303 CA 125 production of human ovarian cancer cell lines and their cell kinetics under the addition of several drugs.
304 Study on the significance of tumor marker CA125 kinetics in ovarian cancer chemotherapy.
305 Immunocytochemical demonstration of alpha-1-antitrypsin and alpha-fetoprotein in mesonephros.
306 Clinicopathological study in endodermal sinus tumor of the ovary.
307 An immunohistochemical and electron microscopic study on the case of embryonal carcinoma with high level of serum α-fetoprotein.
308 Effect of gonadotropins on the Protein kinase C activity of the malignant ovarian neoplasms.
309 Inhibitory effects of tamoxifen, and clomiphene on human ovarian cancer cell proliferation.
310 Ovarian and serum inhibin levels in immature female rats : relationships of inhibin and serum FSH concentrations.
311 Studies on the suppression mechanism of follicle-stimulating hormone (FSH) release by porcine follicular fluid (pFF).
312 Immunohistochemical localization of inhibin subunits in human ovarian folllicles during the menstrual cycle.
313 Cellular localization of inhibin subunits in human corpus luteum during the menstrual cycle and pregnancy.
314 Serum levels of inhibin in maternal and umblical blood during pregnancy.
315 Changes in Serum Maternal and Neonatal Immunoreactive Inhibin Levels during Perinatal Period.
316 The effects of epidermal growth factor on follicle-stimulating hormone receptor in the porcine granulosa cells.
317 Regulation of epidermal growth factor (EGF) receptor in porcine granulosa cells by follicle-stimulating hormone (FSH).
318 ESTRADIOL STIMULATES THE BINDING OF EPIDERMAL GROWTH FACTOR (EGF) TO CULTURED RAT GRANULOSA CELLS.
319 EGF promotes the growth of mouse uterus and vagina in vivo.
320 Physiological function of epidermal growth factor (EGF) in uterine enlargement and aging of the uterus in mice.
321 The relationship between occulted hyperprolactinemia and ovarian function.
322 The role of melatonin in the prolactin secretion of normal women.
323 Relationship between biological activity of serum prolactin (PRL), TRH test and ovarian function.
324 Immunological studies on habitual aborters with prolactin disorders.
325 Inhibitory effect of L-Dopa on the acceleration of prolactin secretion during exercise.
326 Suckling stimulation increases hypothalamic VIP mRNA amount. : VIP has a role of PRF.
327 Specific binding of Vasoactive intestinal polypeptide (VIP) to decidual cells and its effects on the prolactin production.
328 Biochemical characterization and comparison of prolactin microheterogeneity between blood and amniotic fluid.
329 Morphological studies of the transport of decidual prolactin by fetal membranes.
330 Catecholaminergic innervation of LHRH Neurons in the Rat Medial Preoptic Area Analyzed by Electron Microscopy and Double Immunolabeling.
331 Gene expression of gonadotropin releasing hormone (LHRH) in the rat hypothalamus.
332 Clinical meanings of the delayed reaction type in the LH-RH test in sterile women.
333 Elevation of serum gonadotropin in response to TRH in women with hypothalamic amenorrhea.
334 Revaluation of "hypothalamic" amenorrhea by clomiphene citrate.
335 Acute and chronic effects of gonadal steroids on pulsatile and interpulse gonadotropin secretion from perifused rat pituitary cells.
336 Possible involvement of IL-6 in the mechanism of hypothalamic Gn-RH secretion induced by estradiol.
337 The effect of insulin-like growth factor (IGF) on gonadotropin release from hypothalamus-pituitary axis in vitro.
338 Stimulatory role of substance P (SP) on gonadotropin release in rats.
339 THE ROLE OF ANGIOTENSIN IN PARACRINE INTERACTION BETWEEN RAT ANTERIOR PITUITARY CELLS.
340 Effect of cAMP and adenosine nucleotides on hCG production by trophoblastic cells.
341 Roles of disulfide bonds in human chorionic gonadotropin (hCG) and lutropin (LH).
342 Site-specific mutagenesis of human chorionic gonadotropin(hCG)-β subunit : influence of mutation on hCG production.
343 Purification and phosphorylation of luteinizing hormone receptor.
344 Evidence for a role of Plasminogen activator and Plasmin in Ovulation in In Vitro Perfused Rat Ovaries.
345 Influence of progesterone on ovarian blood volume during ovulation in the gonadotropin-primed immature rat.
346 The Role of SOD on Mechanism of Ovulation.
347 Effect of Prostaglandin and Histamine on ovarian blood flow and ovulation.
348 Hyperinsulinemia as a risk factor for endometrial carcinoma.
349 The effect of Estrogen on endometrial carcinoma transplanted into nude mice.
350 Specific action of norethisterone on nucleolar organizer regions in endometrial carcinoma cells.
351 The histological effects of high dose administration of sex steroids on mammary tumors and uterine tissues in immature hyperprolactinemic female rats.
352 Protein kinase c activities in human endometrium.
353 Growth promotion by transforming growth factor-β in human endometrial cancer cells.
354 Histochemical study on blood group substances in endometrium with special reference to the expression of type I chain.
355 Immunohistochemical and biochemical investigations of glutathione peroxidase on endometrial carcinoma and hyperplasia.
356 Ultrastructural studies on the basement membrane and the stroma in atypical hyperplasia (ATH) and well-differentiated carcinoma (G1) of the endometrium.
357 Electron microscopic studies on adenosquamous carcinoma and adenoacanthoma of the endometrium.
358 A study of invasion mechaism : interaction between endometrial cancer cells (NTK-1) and extracellular matrix.
359 Characterization of UMM-2 cell strain established from a human uterine malignant mixed mullerian tumor.
360 The different expression of glycolipids between epithelial and non-epithelial cell lines derived from gynecological malignant tumor.
361 N-myc gene amplification in germ cell tumor cell strains.
362 Studies on ras oncogene activation in gynecologic neoplasia.
363 An approach to new cancer therapy : differntiation therapy.
364 BASIC STUDY ON PLASMAPHERESIS USING NEW ADSORPTIVE COLUMN : IMPROVEMENT OF CANCER CACHEXIC CONDITION.
365 Prognostic significance of the DNA content of uterine corpus cancer.
366 Flow Cytometric Analysis of DNA and Cell Proliferation in Endometrial Carcimona : Correlations with Degree of Differentiation, Tumor Myometrial Invasion and Tumor Vessels Permeation.
367 DNA analysis of endometrial adenocarcinoma using a flow cytometry.
368 Multi-parametric analysis of genotype and phenotype in dufferentiation of human endometrial adenocarcinoma cells.
369 Growth potential examined by Ki-67 Ag/DNA two color assay in cervical cancer and endometrial cancer.
370 Treatment of Stage II endometrial carcinoma.
371 An analysis of prognostic significance of new FIGO staging system (1989), nuclear grade and lymph-vascular space invasion in endometrial carcinoma.
372 Prognostic significance of paraaortic node metastasis in endometrial carcinoma.
373 Computed tomography and transrectal ultrasonography in endometrial carcinoma.
374 Study on prognostic factors of Mullerian mixed tumor of the uterine corpus.
375 Fundamental study of the clinical application of CDDP-microcapsules.
376 Cancer chemotherapy using a subcutaneously implanted intravenous catheter.
377 RF capacitive hyperthermia for gynecologic field
378 Total parenteral nutrition (TPN) using imbalanced (methionine deprived) aminoacids solution in chemotherapy for ovarian cancer.
379 Experimental study of combination chemotherapy of Cisplatin and Etoposide for gynecological cancers.
380 Study of relationship between nuclear DNA content and drug sensitivity of human gynecological cancer transplanted into nude mice.
381 Application of BrdU/DNA and Ki-67 Ag/DNA two color assay to anticancer agent sensitivity test.
382 Immunohistochemical detection of interaction product of cisdiamminedichloroplatinum with DNA in uterine cancer.
383 Establishment, Characterization and In vitro Chemosensitivity Study of Multiple cell lines from a single Human Uterine Cervical Adenocarcinoma.
384 Development of Resistance to Anticancer Drugs in NIH3T3 Cells Transfected with c-myc and/or c-H-ras Genes.
385 The expression of P-glycoprotein on the surface of anticancer drugs resistance cell lines.
386 Preclinical study on enhancement of antitumor effects of cisplatin and circumvention of cisplatin-resistance.
Growth inhibitory effects of anti-cancer drugs and steroid hormones, and the combined effect of Ca antagonist (Verapamil) on endometrial stromal sarcoma cell line (OMC-6).
388 Study on the fetal teratogenesis in diabetic pregnancy using whole embryo culture system.
389 Study of insulin resistance in isolated fat cells from pregnant and nonpregnant women.
390 Doppler velocimetry in pregnancy complicated with diabetes mellitus
391 Feto-placental circulation in pregnancy complicated by diabetes mellitus.
392 When should glucose challenge tests be performed during pregnancy?
393 Correlation between the delivery of HFD baby and serum 1,5-anhydro-D-glucitol levels in pregnant women.
394 Follow-up of gestational diabetes (DGM) delivety and evaluation of the index to predict the development to DM.
395 The analysis of pathological changes of the placenta with the degree of diabetic control.
396 Managements of pregnants with glucose intolerance using random blood glucose levels as a screeing test.
397 Correlation of umbilical flow and pathological findings of the placenta to fetal growth in pregnancy with SLE.
398 Management of 12 pregnancies with Eizemenger's syndrome.
399 The study of guideline for pregnancy assessment in renal transplant recipients.
400 Role of α-atrial natriuretic peptide (α ANP) in human fetal membranes.
401 Expression of placental alkaline phosphatase and hPL gene in placenta during pregnancy.
402 Decreased placental aromatase in anencephalic pregrancy, measured by ELISA.
403 Clinical applicaton of the direct assay system for the measurement of sex steroid hormones in serum using high-performance liquid chromatography (DHAS-loading test).
404 Aminopeptidase A and cystine aminopeptidase in pregnant serum.
405 The change of serum levels of aminopeptidases in pregnat women.
406 Placental Protein PP19 : Synthetic capability by trophoblastic cell in vitro and the molecular biological analysis.
407 Establishment of the monoclonal antibody against placental protein 19 (PP19) and its immunohistochemical examination in differentiation of trophoblast.
408 Basic fibroblast growth factor (b-FGF) in the human placenta.
409 Lipids status in feto-maternal units, especially on lipid-peroxidation and scavenger system.
410 Endothelin levels in pregnancy and identification of its receptor in human term placenta.
411 Plasma Endothelin-1 levels during pregnancy and at delivery
412 The study of the concentration of endothelin in maternal veins, umbilical veins and arteries by sandwich-EIA.
413 Plasma endothelin levels in normal and hypertensive pregnant women.
414 The Effect of endothelin on isolated blood vessels of pregnant SHR.
415 Placental transfer of ritodrine and its effect on woman and neonate.
416 The outcome in infants of the patients admitted at between 16 and 23 weeks of gestation with high tocolytic index.
417 The early detection of chorioamnionitis by measurement of elastase activity of cervical mucus.
418 Clinical utility of APR score concerning the management of Preterm PROM.
419 Antibacterial activity of amniotic fluid and zinc.
420 Estimation of prognosis of early pregnancies by fetal heart rates.
421 The Classification of Hydatidiform Mole by DNA Fingerprint Method : The Discrepancy in the Diagnoses by Macroscopical and Microscopical Findings and the DNA Fingerprint Method.
422 Immunohistochemical study of placental antigens, ras and myc oncogene products in trophoblastic disease.
423 Identification of a chromosome controls various transformed phenotypes of a choriocarcinoma cell line CCl by microcell-mediated chromosome transfer.
424 Cytomorphological reappraisal of choriocarcinoma cells : A proposal of a four cell pattern.
425 Relationship between the cell cycle and production of hCG in choriocarcinoma cells.
426 Studies on the in vitro growth inhibitory effect of Bestatin to the choriocarcinoma cells.
427 Evaluation of magnetic resonance imaging in gestational trophoblastic disease.
428 Physiological meanings of Catecholamines and Renin-Angiotensin system on fetal infection. : Use of the experimental infection model on fetal goat
429 GBS infection in mother and newborn.
430 Prevention of vertical transmission of group B streptococcus by vaginal and ano-rectal culture and assay of type-specific antibody in pregant women.
431 On the High Risk Factor of Home Chemotherapy for Gynecologic Cancer.
432 The significance of measuring fractionated TPHA in cases of syphilis during pregnancy.
433 Adherence of Candida albicans to vaginal epithelial cells.
434 Therapeutic effect of interferon alpha on human papilloma virus (HPV) infection of the cervix or vagina. : evaluation by histo-cytological and DNA hybridization study
435 Comparision between detectable rate of HPV infection by VIRA PAP and by cervical cytological smear.
436 Epidemiological investigation of human papillomavirus (HPV) in genital tract.
437 Detection of IgM antibody against Chlamydia in newborns as an examination of Chlamydia trachomatis infection of the birth canal.
438 The role of Chlamydia trachomatis in preterm labor.
439 The significance of in situ DNA hybridization of chlamudical Infection in Female Genital Tract.
440 Correlation between serum IgA and IgG antibodies specific for Chlamydia trachomatis and the incidence of spontaneous abortion and preterm delivery, studied in pregnant women retrospectively.
441 Detection of HTLV-I provirus using the polymerase chain reaction.
442 Protection of HTLV-I mother to child infection by avoid breast-feeding and anti-HTLV-I antibody production on HTLV-I antigen positive carriers.
443 Infectivity of HTLV-1 infected lymphocytes in breast milk of HTLV-1 carrier mothers.
444 Mother-to-child transmission of HTLV-I detected by polyserase chain reaction (PCR).
445 Significance of Measuring Anti-P40^ Antibody in Mother-to-Child Transmission of HTLV-I.
446 Application of fuzzy theory to Apgar scoring system.
447 Fetal Weight Estimation Using Similar Cases Based on the Fuzzy Theory.
448 The automatic screening system of the high-risk pregnancy using home telemetry through the computer network.
449 Effect of pulsed ultrasound irradiation on preimplantation mouse embryo development.
450 Evaluation of true non reactive pattern by actocardiogram.
451 Studies on relation between fetal heart rate rise and duration of fetal movement with ultrasonic Doppler actocardiograph.
452 Frequency analysis of fetal heart rates (FHR) by maximum entropy method (MEM) : Quantitative analysis of short term variability (STV)
453 Spectral analysis of human fetal heart rate changes. : Solution of the problems in the analysis and elucidation of heart rate spectral changes with fetal development
454 Study in the relation between spectral analysis on FHR signals and fetal movements.
455 The analysis and availability of vibro-acoustic stimulation test using computerised fetal monitoring system.
456 Study on the prediction of fetal distress at mid-gestation by use of the Nonstress test with vibratory acoustic stimulation.
457 Study of fetal response to Vibrotic Stimulation.
458 The Vibroacoustic Stimulation Test (VAST) and its effects on fetal movement, heart rate and habituation.
459 Ultrasound evaluation of intrauterine cardio-vascular function in the fetuses with congenital heart disease (CHD).
460 Evaluation of cardiac pump function of having cardiac disorder and normally-developed human fetus.
461 Culture of human trophoblast cell and location of M-Colony stimulating factor.
462 Prostacyclin production in human chorionic tissue of immature placentae in culture.
463 Effects of various growth factors on the proliferation and the differentiation of trophoblastic cells in vitro.
464 Effect of thyroid hormone (T_3) on the differentiation of human Placental cytotrophoblast (C cell).
465 Cytofluorometric nuclear DNA analysis and immunohistochemical study on the proliferative activity of the trophoblasts in human eary gestation.
466 Effect of retinoic acid (RA) on endocrine function by trophoblastic cells.
467 Effect of growth factors on differentiation and production of placental proteins of cultured cytotrophoblasts.
468 A modified Aldridge method in total hysterectomy : The method of incising downward both cardinal ligaments and anterior and posterior surface of the cervix.
469 Recent advance in the treatment of vesicovaginal fistula caused after hysterectomy.
470 Review of the cardinal ligament to be dissected in radical hysterectomy.
471 Development of a subcutaneously implantable intraperitoneal drug administration device.
472 LYSIS OF ADHESION AT SECOND-LOOK LAPAROSCOPY FOLLOWING RECONSTRUCTIVE PELVIC MACROSURGERY AND MICROSURGERY.
473 Experimental study of oxdised cellulose (Oxycel) for the prevention of postoperative adhesions.
474 Fundamental study of the Multiform fiber for YAG laser therapy under hysteroscopy.
475 Transcervical resection (TCR) of submucous myoma with hysteroscopic resectoscope
476 Oligonucleotide-DNA typing of HLA-DR genes in recurrent aborters.
477 The risk factor of recurrent abortion due to immunological causes : A singnificance of anti-HLA antibodies.
478 Maternal immune response to paternal antigens in patients with recurrent spontaneous abortion.
479 A clinical analysis on 1000 cases of recurrent spontaneous fetal loss.
480 Studies on the indication of immunotherapy for unexplained recurrent aborters.
481 Analysis of the Mixed Lymphocyte Reaction (MLR)-Blocking Antibodies (BAbs) in the sera of unexplained habitual aborters afer immunotherapy with husband's lymphocytes.
482 The significance of anti-idiotypic antibody in pregnancy.
483 Successful pregnancies in AIH after immunization of husband's lymphocytes.
484 Localization and Production of Human Macrophage Colony Stimulating Factor (hM-CSF) and Granulocyte Colony Stimulating Factro (G-CSF) in Human Placental and Decidual Tissues.
485 Study on phagocytic activity in pregnant women estimated by chemiluminescence response and flow cytometry.
486 Pregnant sera induce selective granulocytic differentiaton of HL60 cells.
487 Detection and characterization of cytotoxic antibody present in pregnancy with idiopathic intrauterine fetal growth retardation.
488 Induction of oncofetal-antigen-I expression and augmentation of immune cytolysis in gynecologic cancer cell lines by IFN-gamma.
489 Imbalance of the Epstein-Barr virus (EBV)-host relationship in the patients with cervical cancer.
490 The fundamental study of anti-tumor effect of In Vitro Sensitized Lymphocytes stimulated by self cancer cells.
491 Anti-Tumor Effects of Cytotoxic T Lymphocytes (CTL) Induced by in vitro Sensitization (IVS).
492 Mechanism of Cytotoxic T lymphocyte induction and activation against autologous tumor cells.
493 Effect of adoptive immunotherapy with tumor infiltrating lymphocytes on advanced ovarian cancer.
494 Adoptive immunotherapy of human endometrial carcinoma using cytotoxic T lymphocytes and newly established carcinoma cell line.
495 Studies on the mammalian implantation in vitro.
496 The role of macrophage in human decidual tissue during early pregnancy.
497 GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) PRODUCTION BY HUMAN DECIDUAL CELLS IN EARLY PREGNANCY.
498 Induction of suppressor cells in co-culture of lymphocytes and trophoblast membrance.
499 IL-1 and TNF-α Produced by Trophoblasts Control Trophoblast-derived IL-6 Secretion.
500 A case report of recurrent nonimmune fetal ascites due to lysosomal storage disease (LSD).
501 Prenatal diagnosis of Prader-Willi syndrome.
502 Maternal steroid sulfatase activity carring a infant with placental sulfatase deficiency.
503 A CASE OF PREGNANCY COMPLICATED WITH PELIOSIS HEPATIS
504 A case of fulminant hepatitis after two weeks of postpartum period.
505 Bone loss following oophorectomy in terms of region and postoperative interval.
506 Study of back and low back pain and osteoporosis with DPA, MD, MD/MS and CR : before and after treatments.
507 Quantitative measurement of spinal bone density by dual energy X-ray absorpsiometry (QDR-1000) : comparison with microdensitometry method.
508 Clinical usefulness of clavicular index as a screening of osteoporosis.
509 Comparison of biochemical parameters of bone metabolism in pre- and postmenopausal women.
510 Decreased bone density in amenorrheic women.
511 The measurement of bone mineral content by Dual enery X-ray absorptiometry (DEXA).
512 The Influence on the Early Changes of Bone Metabolism by Radiation : Measurement of Bone Mineral Concentration of the Lumbar Vertebra by Quantitative Computed Tomography (QCT)
513 Effect of Shakuyaku-Kanzo-To on serum steroid hormone levels after castration and cultured adrenal gland cells of the female rats.
514 Response of plasma adrenal steroid levels to ACTH in menopausal women
515 Changes of steroid enzyme activities with age in human ovary.
516 Changes in urinary estrogens and catecholestrogens in normal women with aging.
517 The effect of dehydroepiandrosterone-sulfate (DHA-S) on the hypothalamic-hypophyseal adrenal function in climacteric women.
518 Psychological state in obese adolescents : consciousness, perception for obesity and depression state.
519 The peculiarities of personality of women with climactric syndrome.
520 Ovarian function and pulsatile secretion of LH.
521 The Effect of Exercise to the Gonadtropin Pulsatile Secretion.
522 Biochemical evaluation of the function on vascular endothelial cells with aging.
523 Effect of catecholestrogens on survival rate, lipid peroxide levels, and hematopoietic function of mice after ^<60>Co γ-irradiation.
524 Studies of the effects of energy metabolism of human muscle follow aginy.
525 Treatment of anemia in pregnancy with Hb levels ranging from 10.0 to 10.9g/dl.
526 The difference in adult and fetal platelets aggregation.
527 Platelet count and platelet-associated IgG level in maternal and cord bloods complicated with or without idiopathic thrombocytopenic purpura.
528 Relationship between fetal distress and erythrocyte deformability at delivery.
529 The studies of Calphobindin (CPB) in breast milk.
530 The influence of Medroxyprogesterone acetate (MPA) to the clotting, fibrinolysis and kinin-kallikrein systems.
531 Effect of chemotherapeutic agents on neutrophil phagocytosis in vivo.
532 Molecular makers of DIC in toxemia preganancy.
533 Platelet ATP release reaction and aggregation in normal pregnant women and the patients with pre-eclampsia.
534 Dose-response relationship for the effects of 5-HT, ADP, and arachidonic acid on the cytosolic free Ca in the platelet of normal pregnant women.
535 Study on the hypercoagulability during pregnancy.
536 Study about prediction of toxemia of pregnancy.
537 Changes in plasma PAI 1, PAI 2 and tPA antigen in normal pregnant and preeclamptic pregnant women.
538 Plasma protein S concentration during normal pregnancy, toxemia pregnancy and preterm baby.
1 Prognostic significance of extrauterine spread of adenocarcinoma of the uterine cervix : Using preparation of the whole parametrial tissue
2 Studies of tissue localization of Sialosyl-Tn antigen in uterine cervical adenocarcinoma.
3 Immunohistochemical Study on the MHC Class II Antigen Expression and Lymphocytes Infiltrating in Uterine Cervical Carcimomas.
4 Immunohistochemical analysis of MHC Class I expression on the uterine cervical cancer cells.
5 Chromosome changes associated with tumorigenic phenotypes obtained by 3Y1 cells.
6 Immunohistochemical localization of Keratin (56KD) and Epidermal Growth Factor Receptor (EGFR) in microinvasive squamous cell carcinoma of uterine cervix.
7 HTLV-I infection as an oncogenic and prognostic risk factor in patients with cervical carcinoma and vaginal carcinoma.
8 Histpathological studies on uterine cervical intraepitherial neoplasia associated with HPV infection.
9 Follow up study of the cervical human papilloma virus infection in the women with cervical intraepithelial neophasia (CIN).
10 Detection of human papillomavirus (HPV) in cervical carcinoma, CIS and severe dysplasia in progressive course by in situ hybridization and PCR.
11 Detection of human papilloma virus in cervical lesion using PCR (polymerase chain reaction). Part 2.
12 A case report of Buschke-Lowenstein tumor and human papillomavirus.
13 DNA synthetic cell analysis in endometrial carcinoma cases by progestogen challenge test.
14 The effect of EGF on glycogen metabolism of human endometrial adenocarcinoma cells.
15 Inhibitory effects of estradiol on growth-promoting activity in human uterine cancer extracts.
16 Immunohistologic studies on basement membrane type 4 collagen in endometrial hyperplasia and endometrial carcinoma.
17 Establishment and characterization of cell line TMCC-2 from clear cell carcinoma of the endometrium.
18 Prognostic factors and it's quantification in endometrial cancer.
19 Immunohistochemical Study in Endometrial Hyperplasia and Carcinoma.
20 Nucleoar organizer regions (NORs) in the neoplastic and preneoplastic lesions in the hunam endometrium.
21 Histopathological statistical differentiation between well differentiated type of endometrial adenocarcinoma (wC) and endometrial adenomatous hyperphasia (aH).
22 Study of localization and morphological characterization of intermediate trophoblast in total hydatidiform mole.
23 Cellular-Molecular Biological Analysis for the Spontaneously drug-resistant Choriocarcinoma Cell.
24 Usefulness of Magnetic Resonace Imaging in diagnosis of trophoblastic disease : comparison of MRI with X ray CT and DSA.
25 Maternal and fetal Prognosis of mild Pregnancy lnduced hypertension diagnosed by two different criteria
26 A MARGIN OF SAFETY OF FETUSES IN PATIENTS WITH SEVERE PREGNANCY INDUCED HYPERTENSION.
27 The effects of normal pregnancy and pregnancy induced hypertension on venous tone.
28 The effects of low calcium diet on the vascular response to angiotensin II (A II) in autoperfused hindquarters of pregnant rats.
29 Effect of taurine concentration in platelets on platelet aggregation induced ADP or collagen.
30 Estimation of coagulatory regulation and endothelial cell function in pregnancy by the study of tissue plasminogen activator (TPA) and thrombomodulin (TM).
31 Role of endothelial and endometrial cells in placental fibrinolysis. : based on the assay of tPA and PAI production in the cell culture.
32 A study on the Prediction of Toxemia.
33 The Dynamics of ACTH, cortisol and corticosteroid-binding globulin (CBG) levels in Maternal and Fetal Plasma in complicated pregnancies.
34 Circadian rhythms of steroids in normal maternal plasma at during pregnancy Ist, IInd, IIIrd trimester and anencephalus.
35 Doppler ultrasound investigation of human feto-placental blood flow and the study of hormoanl mechanisms.
36 Purification and characterization of insulin-like growth factor-binding protein in human amniotic fluid using monoclonal antibodies.
37 Effect of dipalmitoyl lecithin on leukotriene producion.
38 PGI2 production and Ca++ kinetics in vascular endothelial cells of pregnant rats (second report).
39 Biosynthesis of prostaglandins (PGs) in the rabbit uterine cervical tissue with the process of gestation.
40 Outcome of pregnancies complicated with chlamydia trachomatis or herpes simplex virus infection in the first trimester.
41 The significance of bacterial culture in PROM/ROM patients
42 Umibilical artery flow velocities and the placental vascular bed in patients with lupus anticoagulant.
43 Structural studies of Wharton's jelly of the human umbilical cord from early pregnancy to full term.
44 Permeability of the human amniotic epithelium.
45 The survey of obstetric emergency and the role of the Perinatal Center in the Prefecture.
46 Quantitative study of human complement in the sera or ascites fluids which to immobilize spermatozoa.
47 Immunological studies of human endometrium : Effects of endometrial IgG on PHA induced T-cell mitogenesis
48 Trophoblast and materno-fetal immune responses.
49 Heterogeneous expression of three subclasses of Fcγ receptor on human chorion and decidua.
50 Changes of lymphocyte subsets in pheripheral blood before and after operation of patients with advanced ovarian carcinoma.
51 A study on two-color analysis in peripheral lymphocytes of concomitant use of sizoriran (SPG) on cervical cancer treated with radiation.
52 A New Criteria to Choose a Bromocriptine Therapy.
53 The change of gonadotropin-releacing hormone (GmRH) gene expression after gonadotropin stimulation in the rat ovary.
54 IL-6 and IL-6 receptor regulate human chorionic gonadotropin in human trophoblasts.
55 EGF receptor gene expression by TGF-β in mammary epithelial cells in culture.
56 Effect of aromatase inhibitors on the growth of MCF-7 human mammary carcinoma cells.
57 Effects of sex steroid on cellular immunity : cytokine production and proliferation of peripheral blood mononuclear cells (PBMCs).
58 Immunohistochemical localization of estrogen receptors and progesterone receptors in the human ovary throughout the menstrual cycle.
59 Effect of dopamine and D_2 receptor agonist (LY171555) on steroidogenesis of cultured porcine and human granulosa cells.
60 Luteotropic effect of prostaglandin F_<2α>, prostaglandin E_2, hCG and their effect on intracellular Ca^<2+> in human cultured luteal cells.
61 Study of endocrine profile and response to clomiphene in polycystic ovary diagnosed with transvaginal ultrasound.
62 Why the pregnancy rate is low in the patients with PCO (Poly Cystic Ovary).
63 Study of energy metabolism in ovulation period by ^<31>P-NMR spectroscopy in perfused rabbit ovary.
64 Evaluation of fetal circulation with the combined echosonography method.
65 Fetal anterior, middle and posterior cerebral arterial hemodynamics assessed by color and pulsed Doppler ultrasound.
66 Fetal well-being assessment by the umbilical artery velocity waveform : Its relationship with values of umbilical venous blood obtained by cordocentesis.
67 Evaluation of fetal heart rate variations with advance in gestation using a probability matrix.
68 Electronic medical record system using personal computers in OBGY outpatient clinic and inpatient ward.
69 An ultrastructural evaluation of a Surfactant-like (Sf) substance in the human endometrium.
70 An In-vivo Study on the Mechanism of CA 125 Production of Endometrial Cells.
71 The expression of estrogen receptor mRNA in human endometrium.
72 Anti-estrogenic effects of gestrinone : Type II estrogen binding sites in uterine nuclear fractions.
73 A Study on histological localization of glycoproteins in the glands of human uterine cervix.
74 The localization of tenascin in the human uterus.
75 Culture of decidual cells in pseudopregnant rats and Attachment of blastocysts to cultured cells.
76 Studies on the localization of adhesive factors at the site of implantation in the early pregnancy.
77 Diagnosis of endometriosis by diagnostic imaging.
78 Capacity of endometriotic implants to synthesize prostaglandins.
79 Immunohistochemical Study of Endometriosis in Pelvic Lymph Node : Comparison to Metastatic Lesion of Endometrial Carcinoma.
80 Functional examination of the peritoneal macrophage in endometriosis patient. : the effect of suppression of macrophage function
81 Sperm transport in the human female reproductive tract in infertile women with endometriosis.
82 Ethanol infusion therapy for cystic pelvic masses.
83 Nd:YAG laser contact therapy of ovarian endometriosis under laparoscopic control.
84 Comparison Between Transvaginal Sonographic Appearance and Endometrial Histology.
85 Relationship between measurement of endometrium and outcome of treatment of sterility.
86 Analysis of hysteroscopic assessment for luteal phase endometrium in infertile women.
87 Study on the accuracy of endometrial dating.
88 Prognosis of threatened abortion assessed by multivariate analysis.
89 Ultrasonographic studies on the clinical significance of low-lying placenta : by transvaginal and transrectal route
90 Molecular size analysis of urine protein using immunoblot method in preeclampsia.
91 The significance of DHAS half-life for the pregnant women of twin, toxemia and intrauterine growth retardation (IUGR).
92 Prenatal diagnosis of 21-hydroxylase deficiency with DNA analysis.
93 Clinical study of epithelial ovarian carcinoma in our hospital.
94 Combination of intra-peritoneal and intra-arterial cisplatin(CDDP) for stage III and IV ovarian cancer.
95 Analysis of follow up laparoscopies (LS) 231 times in 91 patients with ovarian cancer after initial treatmet.
96 Clinicopathological investigations of 14 cases of dysgerminoma.
97 Clinical study of recombinant human Granulocyte Colony Stimulating Factor (rhG-CSF) for high dose chemotherapy with autologous bone marrow transplantation.
98 Effect of human recombinant Granulocyte Colony-Stimulating Factor on Proliferation of gynecological tumor cell lines.
99 Establishment of a new monoclonal antibody (SH-9) and its characteristics in the diagnostic field of ovarian tumors.
100 Expression of Lectin and Blood Group Antigens of the Ovarian epithelial tumors.
101 Study on the growthh control mechanisms of human ovarian cancer cells : Special reference to bioactive substances in the serum-free conditioned medium.
102 Immunohistochemical analysis of endometrial carcinoma and ovarian carcinoma cases using monoclonal antibody of EGF, EGFR, ER and PR.
103 Factors affecting carcinoembryonic antigen (CEA) synthesis and secretion by cultured human ovarian cancer cells.
104 Effects of International Injection of OK-432 with Mitomycin C on the Concentrations of Tumor Necrosis Factor and Interferon-γ in Peritoneal Fluid.
105 Efforts of Human Cord Serum (HCS) and Biological Responce Modifior (BRM) in Sensitivity Test for Anti-tumor Agents : Study on in vitro assay
106 Establishment and characterization of human clear cell carcinoma cell line (OVISE).
107 A case report of ovarian immature teratoma with N-myc gene amplification.
108 The classification of DMBA-induced ovarian cancer in rat
109 Umbilical venous blood gas analysis in normal pregnancies.
110 Cordocentesis for diagnostic indications : Experience of 83 consecutive cases.
111 The predictive evaluation of FAST on abnormal fetuses.
112 Measurement of fetal blood flow velocities after vibratory acoustic stimulation.
113 Ultrasonographic Evaluation of The Development of Fetal Gastric Function.
114 The rhythm of body temperature in premature babies.
115 Incidence of respiratory distress syndrome and neonetal outcome during the last eleven years and its obstetric background.
116 Effects of angiotensin II (ANG II) and phenylephrine (PHEN) on ovine fetoplacental prostaglandin production.
117 Experimental growth retardation in the fetal rat.
118 Induction of true precocious puberty in female rats.
119 The relationship between muscular strength and steroid levels in pubertal girls.
120 Autonomic function in weightloss related amenorrhea examined by R-R interval test.
121 A prospective study of psychosomatic consequence of hysterectomy.
122 Approach to the quantitative measurment about reaction of the autonomic nervous by variation of digital plethysmogram under a cold-water challenge test (CWT) in women with climacteric disturbance.
123 Endocrine status of climacteric women who complain of depression or unidentified complaints.
124 Bone mineral desity (BMD) of the spine and femur using dual energy X-ray absorptiometry (DEXA) in healthy Japanese women.
125 HYSTEROSCOPIC KIMOGRAPHIC PNEUMOTUBATION TEST (HKPT) : A new method for the evaluation of the fallopian tubal functions.
126 Influence of epithelium cells of fallopian tube on mono cell embryos.
127 The Histologic Evaluation and Treatment of Occlusion of the Tubal Pars Interstitialis : Tubo Uterine Anastomosis
128 Evaluation of human sperm acrosome reaction of frozen semen using triple stain technique.
129 Variability in the sperm penetration rate in the hamster egg test during a year.
130 Antithrombin-III and Spontaneous Abortion with Unknown Etiology in Mice.
131 Pregnancy from cryopreserved pronuclear stage embryo, and his born.
132 Birth after cryopreservation of the human embryos : Japan's first case.
133 Effect of torehalose on cryopreservation of mouse 2 cell embryos.
134 Co-culture of mouse 2-cell embryos with various kinds of mono-layer cells.
135 Antifertility effect of vaccination with ZP4 antigen isolated from porcine zona pellucide in hamsters.
136 Efficacy of a gonadotropin-releasing hormone agonist treatment (long protocol) for in vitro fertilization.
137 Evaluation of the adjunct use of GnRH analog (GnRHa) in IVF-ET program.
138 Predicting pregnancy outcome after IVF-ET using estradiol (E_2), progesterone (P) and human chorionic gonadotropin β subunit (β-hCG)
139 Endocrinological aspect of transient hyperprolactinemia in an in vitro fertilization and embryo trasfer.
140 Endometrial thickness and prognosis in IVF-ET cycles.
141 Neurogenic bladder after radical hysterectomy and radiation for cervical cancer-examiation by urodynamic study (UDS) and therapy of β_2-stimulant-.
142 Characteristic findings for localization and extent of endometrial carcinoma in diagnostic imagings, that is USG, X-CT and MRI, and establishment of combined diagnostic imaging system.
143 Evaluation of signal intensities of MRI on diagnosing the invasion of uterine cervical cancer.
144 MRI of Endometrial Carcinoma.
145 Study of the levels of new tumor marker, Basic fetoprotein (BFP) in comparison with that of CA125, CA19-9 and SLX in the gynecological disease.
146 Clinical usefulness of three new ovarian tumor markers, CA54/61, CA602 and caGT.
147 HTLV-1 familial clustering and significance of HTLV-1 provirus detection by polymerase chain reaction.
148 Useful screening for HTLV-1 carrier pregnants with new enzyme immunoassay using gag-env hybrid antigen (GE).
149 Determination of human herpes virus 6 (HHV-6) antibody during pregnancy.
150 The significance of DNA probe test for the diagnosis of Chlamydia trachomatis infection in female genital tract.
151 Ureaplasma Urealyticum : its role in perinatal infection
152 Clinical and pathogenic investigation on fungal vulvovaginitis.
153 A case of amylase-producing ovarian carcinoma.
154 A case report of leiomyosarcoma of the small intestine was diagnosed a torsion of ovary.
155 A case of maternal death due to fluminant hepatic failure : acute lymphocytic leukemia in pregnancy.
156 DNA diagnosis of mos 45, X/46, X, +mar detected by prenatal chromosome analysis.
157 Intrauterine treatment of urinary tract obstruction.
158 Fetal death by measles viral infection of the placenta at 25th week of gestation.
会員入退会
地方部会の動き
学会研究会案内
7月受付原稿
日本医学会だより
日本学術会議だより
読者からの手紙に関する投稿規定
裏表紙
CONTENTS
